ka.batista
TL2 · Izmir
Contributes reviews on supplier material. Based in Izmir.
Joined 27 November 2024 · last posted 4d
86 posts, newest first. Showing up to 150.
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #51 · Compounds › Repair & healing peptides · 24 Jul 2026 · 0 likes BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
-
Sleep quality changes during weight loss Replied, post #27 · Wellbeing › Sleep · 23 Jul 2026 · 0 likes Building on post #24 rather than restating it. Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt sleep. Dosing timing (morning…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #95 · Analytics › Impurities & related substances · 20 Jul 2026 · 0 likes Post #92 answers the question as asked. The question underneath it is different. Deletion sequences arise from incomplete coupling and are lower by one residue mass.…
-
Coming back to: Telehealth prescribing models in the US Replied, post #15 · Regional › North America · 14 Jul 2026 · 0 likes Nothing in this subcategory is medical or legal advice, and the clinicians posting here say so on their own account. Happy to expand any of that if it is the useful part.
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #56 · Practice › Administration · 13 Jul 2026 · 21 likes Building on post #53 rather than restating it. Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a…
-
Revisiting: What pooling buys you and what it destroys Replied, post #89 · Evidence › Meta-analyses · 13 Jul 2026 · 4 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Athletes in weight-category sports: a different risk calculus Replied, post #18 · Clinical › Special populations · 9 Jul 2026 · 6 likes On post #15 — agreed on the reasoning, with one qualification. Athletes and people in substantial training loads are effectively unstudied, and the questions asked here…
-
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #2 · Start Here › How to Ask · 6 Jul 2026 · 6 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
Conditions that change the calculus rather than forbidding it Replied, post #27 · Safety › Contraindications · 4 Jul 2026 · 7 likes A rodent toxicology finding underlying a contraindication is worth understanding, because it explains why the contraindication is narrow rather than broad. The right…
-
What a reversed-phase purity number actually is Replied, post #21 · Analytics › HPLC & UHPLC · 3 Jul 2026 · 3 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
-
Blinding yourself: practical methods and their limits Replied, post #39 · Research Methods › N-of-1 designs · 2 Jul 2026 · 7 likes Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #54 · Compounds › Oral incretins · 22 Jun 2026 · 2 likes Where I part company with post #52, and it is a narrow parting. The thirty-minute wait before eating is not conservatism. Food in the stomach materially reduces…
-
Insurance and replacement policies, compared Replied, post #23 · Sourcing › Logistics · 16 Jun 2026 · 0 likes Summarising the insurance and replacement policies thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #38 · Analytics › HPLC & UHPLC · 16 Jun 2026 · 6 likes Post #34 describes the usual case. This is about the unusual one. Before anything else: what was the gradient, and at what wavelength? Area percent at different…
-
Pooling trials with different estimands Replied, post #18 · Evidence › Meta-analyses · 11 Jun 2026 · 10 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Blind submission and why it changes minds — the long version Replied, post #114 · Sourcing › Independent verification · 2 Jun 2026 · 23 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.
-
Personal import allowances, compared — a second dataset Replied, post #131 · Access › International · 27 May 2026 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #75 · Compounds › Tirzepatide · 21 May 2026 · 0 likes Taking Tirzepatide and nausea seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison,…
-
Bioimpedance and hydration: why the number moves Replied, post #47 · Outcomes › Body composition · 19 May 2026 · 22 likes Where I part company with post #45, and it is a narrow parting. Standardise the conditions: same time of day, same hydration, same recent training, same machine. Most…
-
Search filters: what is missing Replied, post #59 · Meta › Site feedback · 19 May 2026 · 2 likes Taking post #56 at face value and following it one step further. My position on search filters is current rather than settled. I have revised it once already and I…
-
Private prescribing in the UK: what is actually involved Replied, post #9 · Regional › UK & Ireland · 5 May 2026 · 5 likes MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
-
Request: show the solution author in the topic list — what changed since Replied, post #57 · Meta › Feature requests · 3 May 2026 · 13 likes Tradeoffs: every feature has a cost in maintenance and complexity. Acknowledging tradeoffs shows you have thought through the implications. Adding a source would…
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #28 · Analytics › COA interpretation · 2 Apr 2026 · 0 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Amylin receptor signalling and satiety — what changed since Replied, post #50 · Pharmacology › Receptor biology · 24 Mar 2026 · 0 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
The headache that turns out to be dehydration — the long version Replied, post #12 · Nutrition & Training › Hydration & electrolytes · 22 Mar 2026 · 8 likes This follows post #11 rather than contradicting it. For anyone finding this later: the short answer on headache is that it depends on one thing, and the rest of the…
-
A single out-of-range value on an otherwise normal panel Replied, post #24 · Clinical › Bloodwork · 17 Mar 2026 · 0 likes What I would tell a new member reading about single out-of-range value for the first time: the confident posts are not the reliable ones, and the reliable ones are…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #15 · Analytics › HPLC & UHPLC · 6 Mar 2026 · 0 likes Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
-
Second pass at: Identical chromatograms across two different lots Replied, post #33 · Sourcing › Red flags · 28 Feb 2026 · 23 likes On Identical chromatograms the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
[2026 update] Composite endpoints and the component doing the work Replied, post #14 · Evidence › Trials · 27 Feb 2026 · 0 likes I keep a log for Composite endpoints specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and…
-
Preservatives: function, testing, and limits — one year on Replied, post #2 · Pharmacology › Formulation chemistry · 26 Feb 2026 · 21 likes Where I part company with the opening post, and it is a narrow parting. Agreed on Preservatives, with one qualification that I think matters. The reasoning holds for…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #131 · Access › International · 26 Feb 2026 · 1 like Language barriers in accessing: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #59 · Outcomes › Body composition · 25 Feb 2026 · 0 likes Nothing here is medical advice and none of these measurements is diagnostic on its own. That has held every time I have looked, which is not the same as always.
-
Managing an unplanned gap in supply Replied, post #39 · Access › Shortages · 22 Feb 2026 · 7 likes Narrowing post #38, because the general version has more than one answer. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and…
-
Preprint servers and what screening they do Replied, post #64 · Evidence › Preprints · 22 Feb 2026 · 0 likes Post #63 answers the question as asked. The question underneath it is different. Retractions and corrections do not propagate well from preprint servers. A citation…
-
Forced degradation studies: designing one that is informative Replied, post #9 · Analytics › Method validation · 20 Feb 2026 · 15 likes Adding the measurement that post #7 says would settle it. An independent laboratory's method being different from the supplier's is not a discrepancy. It becomes one…
-
Follow-up: Lyophilisation and why the cake looks the way it does Replied, post #3 · Pharmacology › Formulation chemistry · 5 Feb 2026 · 0 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. The version of Lyophilisation that circulates here is a simplification of a…
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #28 · Evidence › Trials · 5 Feb 2026 · 0 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
-
[2026 update] Currency conversion and the cost you did not see Replied, post #8 · Sourcing › Payments · 3 Feb 2026 · 27 likes Currency conversion is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says…
-
Filter needles: when they help and what they cost you Replied, post #30 · Devices › Syringes & needles · 19 Jan 2026 · 16 likes Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous injection, 27-30G is typical. Finer needles take…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #68 · Regional › UK & Ireland · 14 Jan 2026 · 21 likes Where the Private prescribing discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #26 · Pharmacology › Receptor biology · 25 Dec 2025 · 4 likes Where I part company with post #24, and it is a narrow parting. Amylin signalling reaches satiety through a distinct receptor complex, which is the mechanistic basis…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #6 · Practice › Storage & stability · 20 Dec 2025 · 21 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
-
Aggregates and why a purity assay may miss them entirely Replied, post #9 · Analytics › Impurities & related substances · 15 Dec 2025 · 2 likes Comparing impurity profiles across suppliers is much more informative than comparing purity figures, and almost nobody has the documents to do it.
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #104 · Documentation › Doc review · 2 Dec 2025 · 0 likes Narrowing post #103, because the general version has more than one answer. Worth stating the null on Promotion criteria before we explain it: the observation may be…
-
Second pass at: Fasting versus non-fasting and which tests care Started this topic · Clinical › Bloodwork · 26 Nov 2025 · 9 likes On the subject in the title: Second pass at: Fasting versus non-fasting and which tests care Working notes rather than a conclusion. Posting a small dataset on Fasting…
-
[2026 update] What steady state means for the decision to escalate Replied, post #75 · Practice › Dosing & titration · 13 Nov 2025 · 1 like This follows post #74 rather than contradicting it. The thing about steady state that took me longest to accept is that a plausible mechanism is not evidence of an…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #14 · Practice › Side effects · 8 Nov 2025 · 0 likes The practical version of Dizziness on standing is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
Temperature loggers worth the money — the long version Replied, post #59 · Devices › Cold chain · 19 Oct 2025 · 21 likes Assessing an excursion: if a package sat at room temperature for a time, visual inspection (cloudiness, discoloration, particles) can alert you to problems. Not visible…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #21 · Safety › Adverse events · 14 Oct 2025 · 2 likes Post #20 is the version of this I will quote in future. One addition. Where a symptom began after an escalation and settled after a reduction, that sequence is the…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #130 · Data & Tools › Calculators · 26 Sep 2025 · 23 likes Rounding behaviour is where two tools disagree. One rounding to the nearest graduation and one to two decimal places will produce different advice from identical inputs.
-
A comparison of home results against a laboratory result on the same vial Replied, post #38 · Analytics › Home & field testing · 18 Sep 2025 · 0 likes Reading a colorimetric result at the wrong time is the commonest procedural error. Development is time-dependent and the window is usually narrow.
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #51 · Practice › Dosing & titration · 11 Sep 2025 · 22 likes The failure mode on lowest dose is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.
-
Reading an interaction checker output critically Replied, post #3 · Practice › Interactions · 8 Sep 2025 · 26 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
System suitability injections: if they failed, the run did not happen Replied, post #28 · Analytics › HPLC & UHPLC · 2 Sep 2025 · 16 likes Worth separating two things that post #24 runs together. One more thing on system suitability injections that took me far too long to see: the two figures people quote…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #84 · Data & Tools › Calculators · 16 Aug 2025 · 1 like Adding what did not work for me on titration planner refuses, since the failures never get written up and they are half the useful information.
-
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #30 · Devices › Pens & autoinjectors · 14 Aug 2025 · 8 likes This is the answer, and the reason it is the answer is the more useful part.
-
Publishing an inconvenient result: a case study Replied, post #55 · Sourcing › Independent verification · 25 Jul 2025 · 4 likes Publishing an inconvenient result has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that…
-
A field-by-field walk through a certificate of analysis Replied, post #73 · Analytics › COA interpretation · 16 Jul 2025 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #18 · Sourcing › Vendor reports · 28 Jun 2025 · 14 likes The most useful reply I ever got about vendor documentation pages was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Reading a chromatogram someone posted without axes Replied, post #47 · Analytics › HPLC & UHPLC · 18 Jun 2025 · 0 likes I would call the community position on reading a chromatogram likely rather than established, and I would be comfortable defending that hedge.
-
Follow-up: Requesting a page: what makes a good request Replied, post #42 · Documentation › Wiki requests · 1 Jun 2025 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Follow-up: What other technical communities get right that we do not Replied, post #106 · Lounge › Off topic · 22 May 2025 · 11 likes Non-technical and offered in the right category: the best thing about a forum with no vote score is that the boring accurate answer sits at the same level as the…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #42 · Clinical › Comorbidities · 17 May 2025 · 32 likes Adding a reference point for hepatic steatosis. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
-
Micronutrient status when intake falls substantially Replied, post #3 · Clinical › Bloodwork · 2 May 2025 · 22 likes Picking up post #2: that is the part I would want checked first. Micronutrient status is a good example of a question where the honest answer is boring and the…
-
Coverage for the indication versus for the drug Replied, post #35 · Access › Insurance & coverage · 19 Apr 2025 · 0 likes Taking post #34 at face value and following it one step further. What would change my mind on coverage is a second dataset collected by someone with no stake in the…
-
Review cadence: how often is a page actually re-checked? Replied, post #13 · Documentation › Doc review · 9 Apr 2025 · 13 likes Post #11 and I disagree about the size of the effect, not about the direction. Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it…
-
A promotion I argued against, and why I lost Replied, post #150 · Documentation › Doc review · 27 Mar 2025 · 0 likes The arithmetic in post #148 is right; the assumption feeding it is the part to check. Adding the boring version of promotion, because the interesting version keeps…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #9 · Analytics › Mass spectrometry · 15 Mar 2025 · 15 likes Post #6 is right about the mechanism and I think understates the practical bit. Sample preparation for mass spectrometry can itself introduce modifications,…
-
SNAC and the mechanism of oral peptide absorption Replied, post #6 · Compounds › Oral incretins · 18 Feb 2025 · 3 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
A promotion I argued against, and why I lost Replied, post #85 · Documentation › Doc review · 4 Feb 2025 · 0 likes Objections are genuinely wanted at this stage, because a bad promotion is much harder to undo than a bad reply. Same conclusion as the reply above, reached differently,…
-
Reading a supplementary appendix and finding the interesting part Replied, post #80 · Evidence › Trials · 30 Jan 2025 · 0 likes Small methodological point on reading a supplementary appendix: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #151 · Clinical › Prescriber conversations · 19 Jan 2025 · 14 likes Confirming post #148 from a second method, which matters more than confirming it from a second person. A question phrased as "what would you want to see before…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #96 · Evidence › Journal club · 18 Jan 2025 · 0 likes Worth separating two things that post #92 runs together. SURPASS-2 would be much easier to settle if anyone reported the denominator. Almost nobody reports the…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #120 · Access › Insurance & coverage · 14 Jan 2025 · 24 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
About the Formulation chemistry category Replied, post #3 · Pharmacology › Formulation chemistry · 13 Jan 2025 · 11 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Follow-up: Individual participant data versus aggregate data Replied, post #68 · Evidence › Meta-analyses · 10 Jan 2025 · 24 likes Two sentences on Individual participant data versus aggregate and then I will stop, because the rest is speculation and the thread is better without mine. What is…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #24 · Compounds › Secretagogues & GH axis · 10 Jan 2025 · 12 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #20 · Compounds › Oral incretins · 25 Dec 2024 · 0 likes Adding the boring version of Oral semaglutide bioavailability, because the interesting version keeps getting posted and the boring one is usually right. Check the…
-
Building a sensible monitoring schedule with your prescriber Replied, post #104 · Clinical › Bloodwork · 23 Dec 2024 · 0 likes The practical version of building a sensible monitoring schedule is three sentences long. The rigorous version is three pages and reaches the same conclusion with the…
-
Follow-up: Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #2 · Compounds › Semaglutide · 3 Dec 2024 · 6 likes Confirming the opening post from a second method, which matters more than confirming it from a second person. On identity confirmation: a mass close to 4113.6 Da on the…
-
EMA product information as a primary source — does this still hold? Replied, post #107 · Regional › European Union · 18 Nov 2024 · 0 likes Taking post #106 at face value and following it one step further. Trying to state the EMA product information position in a way that someone who disagrees would…
-
When to suspect the method rather than the sample Replied, post #27 · Analytics › Method validation · 23 Oct 2024 · 12 likes Picking up post #26: that is the part I would want checked first. Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above…
-
The topic list is dense — is that deliberate? Replied, post #26 · Meta › Site feedback · 15 Sep 2024 · 17 likes Topic list is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Chronic kidney disease and the FLOW result Replied, post #16 · Clinical › Comorbidities · 15 Aug 2024 · 6 likes Where a condition is well controlled and where it is not are different questions and the published data rarely distinguishes them.
-
Criticising the method without criticising the authors Started this topic · Evidence › Study critique · 12 Aug 2024 · 30 likes Criticising the method without criticising the authors Writing it up because I had to work it out twice and would rather nobody else did. I was wrong about criticising…
-
Journal club: FLOW and the renal composite, component by component Replied, post #24 · Evidence › Journal club · 10 Jul 2024 · 0 likes On post #23 — agreed on the reasoning, with one qualification. Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded…